Trial ID or NCT#

NCT01460641

Status

not recruiting iconNOT RECRUITING

Purpose

A research study of rectal cancer perfusion (how blood flows to the rectum over time). We hope to learn whether perfusion characteristics of rectal masses may be predictive of response to treatment and whether rectal perfusion characteristics can be used to follow response to treatment.

Official Title

Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

R Brooke Jeffrey
George A. Fisher Jr.
George A. Fisher Jr.
Medical oncologist, Gastrointestinal specialist
Colleen Haas Chair in the School of Medicine
Teri A Longacre
Teri A Longacre
Pathologist, Surgical pathologist, Immunodiagnosis pathologist
Richard L. Kempson, MD, Professor in Surgical Pathology
Dominik Fleischmann
Dominik Fleischmann
Radiologist, Cardiologist
Professor of Radiology (Cardiovascular Imaging)
Uri Ladabaum
Uri Ladabaum
Medical oncologist, Gastroenterologist, Geneticist, Cancer geneticist, General gastroenterologist
Professor of Medicine (Gastroenterology and Hepatology)
Subhas Banerjee
Subhas Banerjee
Gastroenterologist, Therapeutic endoscopy specialist, Biliary specialist, Endoscopic ultrasound specialist
Professor of Medicine (Gastroenterology and Hepatology)
Daniel Rubin
Daniel Rubin
Radiologist
Professor of Biomedical Data Science and of Radiology (Integrative Biomedical Imaging Informatics at Stanford), of Medicine (Biomedical Informatics Research) and, by courtesy, of Ophthalmology and of Computer Science
Daniel Chang
Daniel Chang
Radiation oncologist
Sue and Bob McCollum Professor
Andrew A. Shelton, MD, FACS, FACRS
Andrew A. Shelton, MD, FACS, FACRS
Colorectal surgeon
Clinical Professor, Surgery - General Surgery

Contact us to find out if this trial is right for you.

CONTACT

Laura Gable
(650) 736-0798